16869455

Source:http://linkedlifedata.com/resource/pubmed/id/16869455

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0025266, umls-concept:C0085542, umls-concept:C0871261, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C1882417, umls-concept:C1956346, umls-concept:C2911692
pubmed:issue	3
pubmed:dateCreated	2006-7-27
pubmed:abstractText	[corrected] The influence ofApoE polymorphism on the efficacy of statins in lowering plasma lipids and lipoproteins and improving angiographic parameters was assessed.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0370570
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anticholesteremic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein E2, http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein E3, http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein E4, http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins E, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/Pravastatin, http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0001-5385
pubmed:author	pubmed-author:De BoerAnthoniusA, pubmed-author:De KnijffPeterP, pubmed-author:HallmanD MichaelDM, pubmed-author:JukemaJ WouterJW, pubmed-author:KasteleinJohn J PJJ, pubmed-author:Maitland-van der ZeeAnke-HilseAH, pubmed-author:ZwindermanAeilko HAH
pubmed:issnType	Print
pubmed:volume	61
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	327-31
pubmed:dateRevised	2009-6-11
pubmed:meshHeading	pubmed-meshheading:16869455-Aged, pubmed-meshheading:16869455-Anticholesteremic Agents, pubmed-meshheading:16869455-Apolipoprotein E2, pubmed-meshheading:16869455-Apolipoprotein E3, pubmed-meshheading:16869455-Apolipoprotein E4, pubmed-meshheading:16869455-Apolipoproteins E, pubmed-meshheading:16869455-Cholesterol, pubmed-meshheading:16869455-Cholesterol, HDL, pubmed-meshheading:16869455-Cholesterol, LDL, pubmed-meshheading:16869455-Coronary Artery Disease, pubmed-meshheading:16869455-Genetic Predisposition to Disease, pubmed-meshheading:16869455-Genotype, pubmed-meshheading:16869455-Heterozygote Detection, pubmed-meshheading:16869455-Humans, pubmed-meshheading:16869455-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:16869455-Male, pubmed-meshheading:16869455-Middle Aged, pubmed-meshheading:16869455-Polymorphism, Genetic, pubmed-meshheading:16869455-Pravastatin, pubmed-meshheading:16869455-Regression Analysis, pubmed-meshheading:16869455-Statistics as Topic, pubmed-meshheading:16869455-Treatment Outcome, pubmed-meshheading:16869455-Triglycerides
pubmed:year	2006
pubmed:articleTitle	Apolipoprotein-E polymorphism and response to pravastatin in men with coronary artery disease (REGRESS).
pubmed:affiliation	Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. A.H.Maitland-vanderZee@pharm.uu.nl
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study